CVS
Long, based on 1D RSI Divergence.
Heavy cost of Aetna acquisition weighed heavily the past year, despite fairly strong earnings.
Although a judge is re-verifying the federally greenlighted merger, posing downside risk, the merger will likely continue through.
Stop loss at 51.50
Order cancelled:
Cancelled, closed out at 51.10
Comment:
54.10*